{"id":113421,"date":"2021-05-03T07:38:27","date_gmt":"2021-05-03T07:38:27","guid":{"rendered":"https:\/\/fin2me.com\/?p=113421"},"modified":"2021-05-03T07:38:27","modified_gmt":"2021-05-03T07:38:27","slug":"siemens-healthineers-raises-outlook-on-demand-for-rapid-covid-19-tests","status":"publish","type":"post","link":"https:\/\/fin2me.com\/business\/siemens-healthineers-raises-outlook-on-demand-for-rapid-covid-19-tests\/","title":{"rendered":"Siemens Healthineers raises outlook on demand for rapid Covid-19 tests"},"content":{"rendered":"
In this article<\/p>\n
German health technology company Siemens Healthineers raised its full-year sales and profit forecast on Monday, as the Covid-19 pandemic continues to drive demand for its rapid antigen tests.<\/p>\n
The group now expects sales to grow 14% to 17% in the year to September, up from a previous forecast for 8% to 12% rise. Adjusted basic earnings per share are seen at 1.90 euros to 2.05 euros versus an earlier forecast of 1.63 euros to 1.82 euros.<\/p>\n
The upbeat outlook is helped by booming demand for the company's Covid-19 rapid tests, which are mainly sold in Germany and generated sales of 190 million euros ($228 million) in the second quarter alone.<\/p>\n
Siemens Healthineers said it now expects rapid antigen test revenue of around 750 million euros for its full fiscal year, up from 300 million to 350 million forecast previously.<\/p>\n
Comparable sales in the January-March period, Siemens Healthineers' fiscal second quarter, rose almost 13% to 3.965 billion euros. Net income increased by 8% to 447 million euros.<\/p>\n
Makers of medical-imaging gear are also benefiting from pent-up demand from hospitals, which delayed ordering in the earlier stages of the pandemic. Dutch rival Philips posted a hefty jump in quarterly profit last week.<\/p>\n
Healthineers said sales in its imaging business were up 7%, driven by double-digit growth in its computed tomography and X-ray products.<\/p>\n
The company aims to become a world leader in cancer care therapy with the $16.4 billion acquisition of U.S. peer Varian, which it completed last month.<\/p>\n